What impact have new minimal residual disease (MRD) assessment techniques had in myeloma?
How can doctors discuss CLL treatment options with patients?
Importance of taking into consideration new and traditional treatment options for CLL patients
Are we seeing any breakthroughs in the treatment of AML?
Predicting and diagnosing TB and CMV in hematopoietic cell transplant recipients